The Use of Busulphan As Compared to Melphalan in Combination with Fludarabine in the Reduced Intensity Conditioning Improves Overall Survival in Patients with Lymphoma

被引：0

作者：

Kekre, Natasha ^{[1
]}

Marquez-Malaver, Francisco J. ^{[2
]}

Caballero, Dolores ^{[3
]}

Pinana, J. I. ^{[4
]}

Esquirol, Albert ^{[5
]}

Soiffer, Robert J. ^{[6
]}

Cabrero, Monica ^{[7
]}

Terol, M. J. ^{[4
]}

Martino, Rodrigo ^{[8
]}

Antin, Joseph H. ^{[9
]}

Lopez Corral, L. ^{[7
]}

Solano, Carlos ^{[10
]}

Armand, Philippe ^{[1
]}

Perez-Simon, Jose A. ^{[11
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Dept Hematol,Inst Biomed Sevilla IBIS, Seville, Spain

[3] Hosp Univ Salamanca, Salamanca, Spain

[4] Hosp Clin Univ, Dept Hematol Oncol, Valencia, Spain

[5] Hosp Santa Creu & Sant Pau, Jose Carreras Leukemia Res Inst, Clin Hematol Serv, Barcelona, Spain

[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[7] Univ Salamanca, Inst Biosanitario Salamanca IBSAL, Univ Hosp, Hematol Serv, E-37008 Salamanca, Spain

[8] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[9] Childrens Hosp, Dana Farber Canc Inst, Massachusetts Gen, Boston, MA 02115 USA

[10] Hosp Clin Univ La Fe, Dept Hematol, Valencia, Spain

[11] Hosp Univ Virgen del Rocio, Dept Hematol, Seville, Spain

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma
Nakano, Nobuaki
Takatsuka, Yoshifusa
Kubota, Ayumu
Tokunaga, Masahito
Miyazono, Takayoshi
Tabuchi, Tomohisa
Odawara, Jun
Tokunaga, Mayumi
Makino, Torahiko
Takeuchi, Shogo
Ito, Yoshikiyo
Utsunomiya, Atae
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (06) : 861 - 871
[42] Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia
DiMaggio, Elizabeth
Zhou, Jun-Min
Caddell, Ryan
Tombleson, Rebecca
Perkins, Janelle
Anasetti, Claudio
Khimani, Farhad
Pidala, Joseph
Nishihori, Taiga
Perez, Lia
Betts, Brian
Fernandez, Hugo F.
Mishra, Asmita
LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1678 - 1687
[43] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Chichra, Akanksha
Nayak, Lingaraj
Kothari, Rushabh
Kalantri, Siddhesh
Bonda, Avinash
Gokarn, Anant
Punatar, Sachin
Mirgh, Sumeet
Jindal, Nishant
Bagal, Bhausaheb
Kannan, Sadhana
Mathew, Libin
Khattry, Navin
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
[44] Fludarabine Melphalan Versus Fludarabine Treosulfan As Reduced Intensity Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplant - a Retrospective Analysis
Chichra, Akanksha
Nayak, Lingaraj
Kothari, Rushabh
Kalantri, Siddhesh Arun
Bonda, Avinash
Gokarn, Anant
Punatar, Sachin
Bagal, Bhausaheb
Kannan, Sadhana
Mathew, Libin J.
Khattry, Navin
BLOOD, 2019, 134
[45] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Akanksha Chichra
Lingaraj Nayak
Rushabh Kothari
Siddhesh Kalantri
Avinash Bonda
Anant Gokarn
Sachin Punatar
Sumeet Mirgh
Nishant Jindal
Bhausaheb Bagal
Sadhana Kannan
Libin Mathew
Navin Khattry
International Journal of Hematology, 2024, 119 : 71 - 79
[46] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma
Majolino, I
Arana, MG
Riccardi, M
Locasciulli, A
Bacigalupo, A
Di Bartolomeo, P
Scimè, R
Olivieri, A
Narni, F
Bregni, M
De Fabritiis, P
Musso, M
Corradini, P
BONE MARROW TRANSPLANTATION, 2005, 35 : S70 - S70
[47] The combination of fludarabine and intravenous busulfan (IVFB) has a more favorable toxicity profile and overall outcome than fludarabine and melphalan (FM) as reduced-intensity conditioning prior to allogeneic stem-cell transplantation (SCT)
Shimoni, A
Yeshurun, M
Hardan, I
Shem-Tov, N
Avigdor, A
Ben-Bassat, I
Nagler, A
EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 61 - 61
[48] Correction to: Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma
Nobuaki Nakano
Yoshifusa Takatsuka
Ayumu Kubota
Masahito Tokunaga
Takayoshi Miyazono
Tomohisa Tabuchi
Jun Odawara
Mayumi Tokunaga
Torahiko Makino
Shogo Takeuchi
Yoshikiyo Ito
Atae Utsunomiya
International Journal of Hematology, 2021, 113 : 950 - 950
[49] Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results
Anderlini, Paolo
Saliba, Rima M.
Ledesma, Celina
Chancoco, Christina
Alousi, Amin M.
Shpall, Elizabeth J.
Popat, Uday R.
Hosing, Chitra M.
Khouri, Issa F.
Nieto, Yago
Ciurea, Stefan
Younes, Anas
Fanale, Michelle A.
Acholonu, Sandra
Valverde, Rosamar
Champlin, Richard E.
LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 499 - 502
[50] Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Epperla, Narendranath
Ahn, Kwang Woo
Armand, Philippe
Jaglowski, Samantha
Ahmed, Sairah
Kenkre, Vaishalee P.
Savani, Bipin
Jagasia, Madan
Shah, Nirav N.
Fenske, Timothy S.
Sureda, Anna
Smith, Sonali M.
Hamadani, Mehdi
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 78 - 85

← 1 2 3 4 5 →